Close

Form 8-K Dolby Laboratories, Inc. For: Feb 02

February 5, 2016 4:38 PM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 2, 2016

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

5.07(a) and (b)

At the Dolby Laboratories, Inc. (the “Company”) 2016 Annual Meeting of Stockholders (the “Annual Meeting”), held on February 2, 2016, at the Company’s principal executive offices located at 1275 Market Street, San Francisco, California, 94103, the Company’s stockholders:

 

  1. Elected nine directors to serve until the 2017 Annual Meeting of Stockholders or until their successors are duly elected and qualified;

 

  2. Approved an advisory vote to approve the compensation of the Company’s named executive officers; and

 

  3. Ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2016.

Each share of the Company’s Class A common stock is entitled to one vote, and each share of the Company’s Class B common stock is entitled to ten votes, on all matters submitted to a vote of stockholders at the Annual Meeting. The Class A common stock and Class B common stock vote together as a single class on all matters submitted to a vote of stockholders at the Annual Meeting. At the Annual Meeting, the holders of Class A common stock and Class B common stock voted as follows:

Proposal 1 – Election of directors:

 

Director

   Votes For      Votes Withheld      Broker Non-Votes  

Kevin Yeaman

     527,632,017         979,242         6,238,164   

Peter Gotcher

     520,042,349         8,568,910         6,238,164   

Micheline Chau

     527,572,904         1,038,355         6,238,164   

David Dolby

     527,237,081         1,374,178         6,238,164   

Nicholas Donatiello, Jr.

     527,584,653         1,026,606         6,238,164   

N. William Jasper, Jr.

     527,098,872         1,512,387         6,238,164   

Simon Segars

     527,494,415         1,116,844         6,238,164   

Roger Siboni

     527,239,438         1,371,821         6,238,164   

Avadis Tevanian, Jr.

     527,723,491         887,768         6,238,164   

All director nominees were duly elected.

Proposal 2 – Approval of an advisory vote to approve the compensation of the Company’s named executive officers:

 

Votes For

   Votes Against    Abstentions    Broker Non-Votes

520,069,701

   8,499,920    41,638    6,238,164

Proposal 2 was approved.

Proposal 3 – Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2016:

 

Votes For

  

Votes Against

  

Abstentions

534,081,365

   722,481    45,577

Proposal 3 was approved.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DOLBY LABORATORIES, INC.
By:  

/s/ Andy Sherman

  Andy Sherman
 

Executive Vice President, General Counsel and Secretary

Date: February 5, 2016



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings